Program
metaxalone
Also written as “Metaxalone Pill”, “Metaxalone 640 mg” and “Metaxalone 800 MG”.
Its studies are mostly in Spinal Stenosis, led by Primus Pharmaceuticals.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Primus Pharmaceuticals | 43 open or running | phase 4since Nov 27, 2023 | Nov 27, 2023 | Jan 15, 2027phase 4 · NCT07801066 |
Also a collaborator on its studies: clinohio-research-services-llc.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 27, 2023First study: phase 4 study in Spinal StenosisFirst studyNCT06157177 · 50 planned · United States
- Mar 30, 2024Phase 4 study in Healthy ParticipantsNCT06348303 · 20 enrolled · United States
- Aug 28, 2026Phase 4 study in Healthy ParticipantsNCT07801066 · 20 planned · United States
- Nov 3, 2026Phase 4 study in Healthy ParticipantNCT07932613 · 20 planned · United States
Ahead
- Nov 15, 2026Primary completion: phase 4 study in Spinal StenosisNCT06157177
- Jan 15, 2027Primary completion: phase 4 study in Healthy ParticipantsNCT07801066
- Jul 15, 2027Primary completion: phase 4 study in Healthy ParticipantNCT07932613
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07932613Healthy Participant · United States | 4 | Not yet recruiting | Jul 15, 2027 | 20 |
| NCT07801066Healthy Participants · United States | 4 | Recruiting | Jan 15, 2027 | 20 |
| NCT06348303Healthy Participants · United States | 4 | Completed | Sep 5, 2024 | 20 |
| NCT06157177Spinal Stenosis · United States | 4 | Recruiting | Nov 15, 2026 | 50 |
How it is read
Names in the registry
- “Metaxalone Pill”, 1 entry
- “Metaxalone 640 mg”, 1 entry
- “Metaxalone 800 MG”, 1 entry
- “Metaxalone 640 mg Oral Tablet”, 1 entry
- “Metaxalone m640 mg oral tablet”, 1 entry
Conditions, from the studies’ own filings
- Spinal Stenosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.